JALOR Sweet Touch : this new product have the usual ideal concentration of 23 mg / ml of cross linked hyaluronic acid with the lowest certified BDDE level in the market and with a 0.3% percentage of lidocaine. the used hyaluronic acid has as usual synthetic origin, therefore totally free of animal proteins. Lidocaine is a local anesthetic which is quickly released into the filler implant reducing the pain caused by the injections and increasing patient's comfort.
NEW J4HA ARCHITECTURE:
The new JALOR Sweet Touch is featured with the most advanced J4HA cross linking technology by which the sophisticated chain structure with different lengths of cross-linked hyaluronic acid based on a higher molecules visco-dynamism provide an increased plasticity of the gel, giving life to a more manageable product in the implant and with both greater yield and durability in the tissues.